Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.

Abstract excerpt

No treatment is available for patients affected by the recessively inherited, progressive muscular dystrophies caused by a deficiency in the muscle membrane repair protein dysferlin. A marked reduction in dysferlin in patients harboring missense mutations in at least one of the two pathogenic DYSF alleles encoding dysferlin implies that dysferlin is degraded by the cell's quality control machinery. In vitro...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Intravenous
• Share to Boronic Acids